ASPN Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
85.2M
+70.9%
49.8M
+31.6%
37.9M
-8.4%
41.3M
-43.4%
73.0M
Cost of Revenue
64.6M
+38.7%
46.6M
+38.6%
33.6M
-47.7%
64.3M
+23.1%
52.2M
Gross Profit
20.6M
+530.1%
3.3M
-23.7%
4.3M
+118.6%
-22929000
-210.2%
20.8M
Operating Expenses
23.1M
-28.0%
32.0M
+27.6%
25.1M
-14.3%
29.3M
+21.3%
24.1M
R&D
2.5M
-22.4%
3.2M
+17.3%
2.7M
-2.5%
2.8M
+12.1%
2.5M
SG&A
20.6M
+3.3%
19.9M
-9.2%
22.0M
+1.3%
21.7M
+8.0%
20.1M
Operating Income
-2509000
+91.3%
-28784000
-38.2%
-20834000
+60.1%
-52222000
-1459.8%
-3348000
EBITDA
2.5M
+110.0%
-24493000
-63.0%
-15025000
+21.9%
-19235000
-632.5%
3.6M
Net Income
-10419000
+55.2%
-23264000
+1.8%
-23691000
+67.5%
-72913000
-1051.1%
-6334000
EPS (Basic)
$-0.13
+53.6%
$-0.28
+3.4%
$-0.29
+67.0%
$-0.88
-1000.0%
$-0.08
EPS (Diluted)
$-0.13
+53.6%
$-0.28
+3.4%
$-0.29
+67.0%
$-0.88
-1000.0%
$-0.08
Shares (Diluted)
83.1M
+0.2%
82.9M
+0.2%
82.7M
+0.1%
82.7M
+0.3%
82.4M
Aspen Aerogels (ASPN) — Financials